Breakthrough As WHO Certifies New HIV Treatment Drug For Pregnant Women

An antiretroviral drug Dolutegravir, commonly known as DTG, has been certified safe for use by pregnant women and those in their reproductive years by the World Health Organisation (WHO). Though initial research linked the drug with neural tube defects (NTDs)

Continue reading…